Abstract
Coronavirus disease 2019 (COVID-19) has rapidly affected mortality in the world, leading to acute respiratory distress syndrome and occasionally into multiorgan dysfunction. Comorbidities are associated with the severity of COVID-19. The impact of underlying respiratory compromises, such as the presence of asthma on the correlated immune status of COVID-19 infection, is still uncertain. There is no clear relationship between COVID-19 and asthma. Therefore, we aimed to perform a systematic review and meta-analysis in order to investigate the association between asthma and poor outcome in patients with COVID-19 pneumonia.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
